SURMONTIL

This brand name is authorized in Spain, Finland, France, Hong Kong, Ireland, Japan, Tunisia

Active ingredients

The drug SURMONTIL contains one active pharmaceutical ingredient (API):

1 Trimipramine UNII 269K6498LD - TRIMIPRAMINE MALEATE

Trimiparamine is a tricyclic antidepressant. It has marked sedative properties. It is, therefore, indicated in the treatment of depressive illness, especially where sleep disturbance, anxiety or agitation are presenting symptoms.

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SURMONTIL Film-coated tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AA06	Trimipramine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AA Non-selective monoamine reuptake inhibitors
Discover more medicines within N06AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 40115
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 436535
Country: FR	Base de données publique des médicaments	Identifier(s): 63344192, 63905138, 64868034
Country: HK	Department of Health Drug Office	Identifier(s): 31113
Country: IE	Health Products Regulatory Authority	Identifier(s): 46108, 47651
Country: JP	医薬品医療機器総合機構	Identifier(s): 1174005B1020, 1174005F1022, 1174005F2029
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6390211, 6390212